HilleVax, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Jun-30-22	Mar-31-22
	10-Q	10-Q	10-Q	10-Q
Assets
Current assets:
Cash and cash equivalents	158.4	260.5	314.6	111.3
Marketable securities	85.7
Prepaid expenses and other current assets	9.0	9.3	4.9	0.5
Total current assets	253.0	269.9	319.5	111.7
Property and equipment, net	13.1	10.5
Operating lease right-of-use assets	18.7	19.0	20.1	0.2
Restricted cash	1.6	1.6	1.6
Other assets	0.0	0.0	0.0	2.8
Total assets	286.5	301.0	341.2	114.7

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable (includes related party amounts of $0 and $141, respectively)	0.2	1.7	6.0	4.0
Accrued expenses (includes related party amounts of $12 and $140, respectively)	17.6	17.4	6.4	4.8
Accrued interest	0.1	0.1	0.0	4.9
Current portion of operating lease liability	0.4	0.0	0.0	0.0
Total current liabilities	18.3	19.3	12.5	282.9
Operating lease liability, net of current portion	23.7	23.0	20.8	0.1
Long-term debt, net of debt discount	24.8	14.9	4.7
Other long-term liabilities	0.9	0.7	0.1	0.0
Total liabilities	67.8	57.9	38.1	283.1

Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.0001 par value; authorized shares-50,000,000 at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022
Common stock, $0.0001 par value; authorized shares	0.0	0.0	0.0	0.0
Additional paid-in capital	538.9	535.2	530.2	4.7
Accumulated other comprehensive loss	-0.3	-0.3
Accumulated deficit	-319.8	-291.9	-227.0	-173.1
Total stockholders' equity	218.8	243.1	303.2	-168.4
Total liabilities and stockholders' equity	286.5	301.0	341.2	114.7